A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy-Reference-Cited by-同舟云学术

A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy

Published:2015-12-17 Issue:12 Volume:10 Page:e0144712
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Taki Shintaro,Kamada Haruhiko,Inoue Masaki,Nagano Kazuya,Mukai Yohei,Higashisaka Kazuma,Yoshioka Yasuo,Tsutsumi Yasuo,Tsunoda Shin-ichi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model;NI Goldstein;Clin Cancer Res,1995

2. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma;DG Maloney;Blood,1997

3. Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma;R Niwa;Cancer Res,2004

4. Antibody therapy of cancer;AM Scott;Nat Rev Cancer,2012

5. Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic;HM Shepard;J Clin Immunol,1991

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eph receptors and ephrins in cancer progression;Nature Reviews Cancer;2023-11-23

2. Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2023-10-01

3. Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody;Antibodies;2023-07-13

4. Eph Receptors in Cancer;Biomedicines;2023-01-23

5. Cancer immunotherapy via nucleic acid aptamers;Aptamers Engineered Nanocarriers for Cancer Therapy;2023